Colostrinin: Completed Phase III study recruitment

Regen Therapeutics plc (LSE:RGT), London, U.K.
Product:

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE